Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDGRI Bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$1.39 | -$1.23 | -$1.31 |
| Q2 2025 | 1 | -$1.11 | -$1.11 | -$1.11 |
| Q1 2026 | 1 | -$1.17 | -$1.07 | -$1.13 |
| Q2 2026 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q3 2026 | 1 | -$0.85 | -$0.85 | -$0.85 |
| Q4 2026 | 1 | -$0.82 | -$0.82 | -$0.82 |
| Q1 2027 | 1 | -$0.73 | -$0.73 | -$0.73 |
GRI Bio, Inc. Earnings Date And Information
GRI Bio, Inc. last posted its earnings results on Monday, August 18th, 2025. The company reported $-1.31148 earnings per share for the quarter, missing analysts' consensus estimates of $-1.11 by $0.20148. The company had revenue of 0 for the quarter and had revenue of 22.54 M for the year. GRI Bio, Inc. has generated $-55 earnings per share over the last year ($-55.21 diluted earnings per share) and currently has a price-to-earnings ratio of -0.3. GRI Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 25th, 2026 based on prior year's report dates.
GRI Bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/12/2025 | Q2 2025 | N/A | -$1.31 | N/A | $0 | $0 |
| 08/12/2025 | Q1 2025 | N/A | -$5.80 | N/A | N/A | $22.54 M |
| 03/17/2025 | Q4 2024 | N/A | -$7.86 | N/A | N/A | $0 |
| 12/16/2024 | Q3 2024 | N/A | -$11.42 | N/A | N/A | $0 |
| 09/16/2024 | Q2 2024 | N/A | -$61.85 | N/A | N/A | $0 |
| 07/31/2024 | Q1 2024 | N/A | -$101.04 | N/A | N/A | $0 |
| 03/15/2024 | Q4 2023 | N/A | -$685.86 | N/A | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$801.55 | N/A | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$4,316.38 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$8,247.52 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | -$5,449.00 | N/A | N/A | $0 |
| 09/29/2022 | Q3 2022 | N/A | -$3,960.17 | N/A | N/A | $0 |
| 06/29/2022 | Q2 2022 | N/A | -$9,476.46 | N/A | N/A | $0 |
| 03/30/2022 | Q1 2022 | N/A | -$17,949.00 | N/A | N/A | $0 |
| 12/30/2021 | Q4 2021 | N/A | -$21,090.00 | N/A | N/A | $0 |
| 09/29/2021 | Q3 2021 | N/A | -$8,562.64 | N/A | N/A | $0 |
| 06/29/2021 | Q2 2021 | N/A | -$15,749.00 | N/A | N/A | $0 |
| 03/30/2021 | Q1 2021 | N/A | -$17,970.00 | N/A | N/A | $0 |
| 12/30/2020 | Q4 2020 | N/A | -$10,009.00 | N/A | N/A | $0 |
| 09/29/2020 | Q3 2020 | N/A | -$7,120.69 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
GRI Bio, Inc. Earnings: FAQ's
GRI Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 25th, 2026 based offlast year's report dates.
The conference call for GRI Bio, Inc.'s latest earnings report can be listened to online.
The conference call transcript for GRI Bio, Inc.'s latest earnings report can be read online.
GRI Bio, Inc. (:GRI) has a recorded annual revenue of $22.54 M.
GRI Bio, Inc. (:GRI) has a recorded net income of $-8,207,000.GRI Bio, Inc. has generated $-55.21 earnings per share over the last four quarters.
GRI Bio, Inc. (:GRI) has a price-to-earnings ratio of -0.3 and price/earnings-to-growth ratio is -0.